129 related articles for article (PubMed ID: 18554583)
21. Mechanisms underlying the vasorelaxant action of the pimarane ent-8(14),15-pimaradien-3beta-ol in the isolated rat aorta.
Hipólito UV; Rodrigues GJ; Lunardi CN; Bonaventura D; Ambrosio SR; de Oliveira AM; Bendhack LM; da Costa FB; Tirapelli CR
Eur J Pharmacol; 2009 Aug; 616(1-3):183-91. PubMed ID: 19540222
[TBL] [Abstract][Full Text] [Related]
22. YC-1 enhances the responsiveness of tolerant vascular smooth muscle to glyceryl trinitrate.
O'Reilly DA; McLaughlin BE; Marks GS; Brien JF; Nakatsu K
Can J Physiol Pharmacol; 2001 Jan; 79(1):43-8. PubMed ID: 11201500
[TBL] [Abstract][Full Text] [Related]
23. Reversal of tolerance to nitroglycerin with vinpocetine: a role of calcitonin gene-related peptide.
Nie SD; Hu CP; Chen YR; Wang S; Deng HW; Li YJ
Int J Cardiol; 2008 Apr; 125(3):436-8. PubMed ID: 17804099
[TBL] [Abstract][Full Text] [Related]
24. N-acetylcysteine-induced vasodilation involves voltage-gated potassium channels in rat aorta.
Han WQ; Zhu DL; Wu LY; Chen QZ; Guo SJ; Gao PJ
Life Sci; 2009 May; 84(21-22):732-7. PubMed ID: 19268479
[TBL] [Abstract][Full Text] [Related]
25. Nitroglycerin-induced release of calcitonin gene-related peptide from sensory nerves attenuates the development of nitrate tolerance.
Ghatta S; O'Rourke ST
J Cardiovasc Pharmacol; 2006 Feb; 47(2):175-81. PubMed ID: 16495753
[TBL] [Abstract][Full Text] [Related]
26. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
[TBL] [Abstract][Full Text] [Related]
27. Effects of phosphodiesterase inhibitors on tension induced by norepinephrine and accumulation of cyclic nucleotides in isolated human prostatic tissue.
Uckert S; Sormes M; Kedia G; Scheller F; Knapp WH; Jonas U; Stief CG
Urology; 2008 Mar; 71(3):526-30. PubMed ID: 18342202
[TBL] [Abstract][Full Text] [Related]
28. Role of mitochondrial aldehyde dehydrogenase in nitrate tolerance.
DiFabio J; Ji Y; Vasiliou V; Thatcher GR; Bennett BM
Mol Pharmacol; 2003 Nov; 64(5):1109-16. PubMed ID: 14573760
[TBL] [Abstract][Full Text] [Related]
29. NT-702, a selective phosphodiesterase 3 inhibitor, dilates rabbit spinal arterioles via endothelium-dependent and endothelium-independent mechanisms.
Mizuno R; Watanabe S; Ohhashi T
J Physiol Sci; 2008 Aug; 58(4):229-37. PubMed ID: 18558016
[TBL] [Abstract][Full Text] [Related]
30. Dissociation of tissue thiols content from nitroglycerin-induced cyclic-3',5'-guanosine monophosphate and the state of tolerance: in vivo experiments in rats.
Haj-Yehia AI; Benet LZ
J Pharmacol Exp Ther; 1995 Apr; 273(1):94-100. PubMed ID: 7714819
[TBL] [Abstract][Full Text] [Related]
31. Effect of phosphodiesterase 5 inhibitor on alteration in vascular smooth muscle sensitivity and renal function in rats with liver cirrhosis.
Tahseldar-Roumieh R; Ghali-Ghoul R; Lugnier C; Sabra R
Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H481-8. PubMed ID: 16373593
[TBL] [Abstract][Full Text] [Related]
32. Selective phosphodiesterase-5 inhibition reduces neointimal hyperplasia in rat carotid arteries after surgical endarterectomy.
Hirschberg K; Radovits T; Loganathan S; Entz L; Beller CJ; Gross ML; Sandner P; Karck M; Szabó G
J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1508-14. PubMed ID: 19464472
[TBL] [Abstract][Full Text] [Related]
33. The flavonoid dioclein is a selective inhibitor of cyclic nucleotide phosphodiesterase type 1 (PDE1) and a cGMP-dependent protein kinase (PKG) vasorelaxant in human vascular tissue.
Gonçalves RL; Lugnier C; Keravis T; Lopes MJ; Fantini FA; Schmitt M; Cortes SF; Lemos VS
Eur J Pharmacol; 2009 Oct; 620(1-3):78-83. PubMed ID: 19686719
[TBL] [Abstract][Full Text] [Related]
34. Pharmacological characterization of a novel phosphodiesterase type 5 (PDE5) inhibitor lodenafil carbonate on human and rabbit corpus cavernosum.
Toque HA; Teixeira CE; Lorenzetti R; Okuyama CE; Antunes E; De Nucci G
Eur J Pharmacol; 2008 Sep; 591(1-3):189-95. PubMed ID: 18593576
[TBL] [Abstract][Full Text] [Related]
35. Nitroglycerin (exogenous nitric oxide) substitutes for endothelium-derived nitric oxide in potentiating vasorelaxations and cyclic AMP elevations induced by calcitonin gene-related peptide (CGRP) in rat aorta.
Fiscus RR; Hao H; Wang X; Arden WA; Diana JN
Neuropeptides; 1994 Feb; 26(2):133-44. PubMed ID: 8170522
[TBL] [Abstract][Full Text] [Related]
36. Endothelium negatively modulates the vascular relaxation induced by nitric oxide donor, due to uncoupling NO synthase.
Bonaventura D; Lunardi CN; Rodrigues GJ; Neto MA; Vercesi JA; de Lima RG; da Silva RS; Bendhack LM
J Inorg Biochem; 2009 Oct; 103(10):1366-74. PubMed ID: 19699534
[TBL] [Abstract][Full Text] [Related]
37. Degradation of leucine zipper-positive isoform of MYPT1 may contribute to development of nitrate tolerance.
Dou D; Ma H; Zheng X; Ying L; Guo Y; Yu X; Gao Y
Cardiovasc Res; 2010 Apr; 86(1):151-9. PubMed ID: 19939965
[TBL] [Abstract][Full Text] [Related]
38. Phosphodiesterase type 5 is highly expressed in the hypertrophied human right ventricle, and acute inhibition of phosphodiesterase type 5 improves contractility.
Nagendran J; Archer SL; Soliman D; Gurtu V; Moudgil R; Haromy A; St Aubin C; Webster L; Rebeyka IM; Ross DB; Light PE; Dyck JR; Michelakis ED
Circulation; 2007 Jul; 116(3):238-48. PubMed ID: 17606845
[TBL] [Abstract][Full Text] [Related]
39. Captopril-induced reversal of nitroglycerin tolerance: role of sulfhydryl group vs. ACE-inhibitory activity.
Lawson DL; Nichols WW; Mehta P; Mehta JL
J Cardiovasc Pharmacol; 1991 Mar; 17(3):411-8. PubMed ID: 1711602
[TBL] [Abstract][Full Text] [Related]
40. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overload-induced right-ventricular remodelling.
Schäfer S; Ellinghaus P; Janssen W; Kramer F; Lustig K; Milting H; Kast R; Klein M
Cardiovasc Res; 2009 Apr; 82(1):30-9. PubMed ID: 19131365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
